1Emiko S, Chiaki N, Akane H, et al. I.ate onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated withchronic graft-versus-host disease and with the graft-versus leukimia effect. Blood, 2003 : 4236- 4242.
1Anderrin P, Rizzo J D. Nugenc M L. et al. Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and european group for blood and marrow trans-plant(EBMT) databases. Bone Marrow Transplant, 2001,27:
2Charnplin R E. Schmitz N, Horoowitz M M,et al. Blood stern cells com-pared with bone marrow as a source of hematopoietic cell for allogenic transplantation. IBMTR histocompatibility and stem cell source working cotnrnittee and the european group for blood
3Ringden O, labopin M, gluckman e, et al. Strong antileukemic effect of chronic graft-versus-host disease in allo-geneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine.The acute leukemia working party of the e
4Pan L, Delmonte J, Jalonen C K, et al. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes donor T-lymptlocyce toward graft-versus-hostdisease. Blood, 1995,86: 4422- 4429.
5Dreger P, Haferlach T, et al. Allogeneic peripheral blood progenitcr cell infusion for treatment of relapse allcgeneic bone transplantation. Blood, 1995,86 (Suppl): 292a-292a.
